Valuation : Haleon plc

Market Cap 31.5B 42.64B 36.69B 34.43B 58.79B 4,031B 59.26B 407B 159B 2,060B 160B 157B 6,634B P/E 2026 *
18.6x
P/E 2027 * 16.5x
Enterprise Value 38.38B 51.95B 44.7B 41.94B 71.63B 4,911B 72.19B 496B 193B 2,510B 195B 191B 8,083B EV / Sales 2026 *
3.37x
EV / Sales 2027 * 3.18x
Free-Float
98.46%
Yield 2026 *
2.26%
Yield 2027 * 2.5%

Last Transcript : Haleon plc

1 day-1.16%
1 week-4.18%
Current month-4.18%
1 month-1.37%
3 months+6.97%
6 months-8.79%
Current year-5.87%
1 week 350.6
Extreme 350.6
373.7
1 month 348.8
Extreme 348.8
374.6
Current year 317.8
Extreme 317.8
416.1
1 year 274.4
Extreme 274.4
416.1
3 years 274.4
Extreme 274.4
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
Manager TitleAgeSince
Chief Executive Officer 59 2021-07-21
Director of Finance/CFO 58 2024-10-31
Chief Tech/Sci/R&D Officer 63 2025-07-31
Director TitleAgeSince
Director/Board Member 59 2022-05-22
Chairman 71 2025-12-31
Director/Board Member 59 2022-07-17
Date Insider Type Main position Quantity % Market Cap. Importance
6/30/26 Free

Chief Financial Officer

283,193 0.0032%
6/30/26 Tax

Chief Financial Officer

-133,301 0.0015%
5/19/26 Others 4,415 0.0000% -
Change 5-day change 1-year change 3-year change Capi.($)
-1.34%-4.18%-3.92%+11.75% 42.64B
-1.26%-2.63%+53.94%+104.89% 1,034B
-0.70%+3.16%+54.68%+72.08% 671B
-1.17%+0.75%+20.85%+76.18% 460B
+0.14%-0.47%+29.49%+38.56% 353B
-1.33%+4.72%+24.69%+45.55% 309B
-1.15%+0.30%-1.49%+12.31% 255B
-1.37%+1.44%+56.60%+72.69% 240B
-0.88%+1.15%-17.09%-54.39% 207B
-0.31%+3.56%+33.78%+100.72% 188B
Average -0.87%+0.82%+25.15%+48.03% 375.94B
Weighted average by Cap. -0.89%+1.00%+36.15%+66.02%

Financials

2026 *2027 *
Net sales 11.39B 15.42B 13.26B 12.45B 21.26B 1,457B 21.42B 147B 57.35B 745B 57.89B 56.63B 2,399B 11.86B 16.06B 13.82B 12.97B 22.15B 1,518B 22.32B 153B 59.74B 776B 60.31B 59B 2,499B
Net income 1.69B 2.29B 1.97B 1.85B 3.16B 217B 3.19B 21.91B 8.53B 111B 8.61B 8.43B 357B 1.92B 2.59B 2.23B 2.09B 3.58B 245B 3.61B 24.78B 9.65B 125B 9.74B 9.53B 404B
Net Debt 6.88B 9.31B 8.01B 7.51B 12.83B 880B 12.93B 88.9B 34.62B 450B 34.95B 34.19B 1,448B 6.27B 8.48B 7.3B 6.85B 11.7B 802B 11.79B 81.03B 31.55B 410B 31.86B 31.16B 1,320B
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (31.4%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - pain relief medicines (23.2%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - respiratory medicines (17%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (15.3%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc.; - medicines for digestive health (8.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - other (4.2%). Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.6%), North America (35.1%), and Asia/Pacific (23.3%).
Employees
24,535
Date Price Change Volume
26-09-04 GBX 352.80 -1.34% 29,946,787
26-09-03 GBX 357.60 -2.30% 21,137,058
26-09-02 GBX 366.00 -1.05% 23,758,744
26-09-01 GBX 369.90 +0.46% 25,449,301
26-08-28 GBX 368.20 -0.35% 18,171,868
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.576GBP
Average target price
4.211GBP
Spread / Average Target
+17.76%

Quarterly revenue - Rate of surprise